ALAranzazu Recio Linares

Aranzazu Recio Linares

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aranzazu Recio Linares has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Alberto Barasoain Millán

    Division of Pediatric Endocrinology, Department of Pediatrics, Hospital Universitario Fundación de Alcorcón, Madrid, Spain

    1 shared publication
  • Carolina Bezanilla López

    Division of Pediatric Endocrinology, Department of Pediatrics, Hospital Universitario Fundación de Alcorcón, Madrid, Spain

    1 shared publication
  • Elia Pérez Pérez Fernández

    Research Unit, Hospital Universitario Fundación de Alcorcón, Madrid, Spain

    1 shared publication
  • Fidel Cano Cano Dorao

    Department of Radiology, Hospital Universitario Fundación de Alcorcón, Madrid, Spain

    1 shared publication
  • Gonzalo Botija

    Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Hospital Universitario Fundación de Alcorcón, Madrid, Spain

    1 shared publication
  • Gonzalo Botija

    Pediatric Gastroenterology Unit Hospital Universitario Fundación Alcorcón Madrid Spain

    1 shared publication

Latest Publications

  • Hepatic steatosis in pediatric obesity: association with cardiometabolic profile and considerations regarding alanine aminotransferase screening

    by Aranzazu Recio Linares, Gonzalo Botija, Carolina Bezanilla López, Alberto Barasoain Millán, Patricia del Olmo Segura, Paula Férreo Santos, Fidel Cano Cano Dorao, Maritza Gonzalez-Hoyuela, Juan Carrero Carrero Álvaro, Thais Garcia Hernando, et al.

    Hepatic steatosis is the most common chronic liver disease in children with obesity and is associated with an adverse cardiometabolic profile. This study aimed to estimate the prevalence of cardiometabolic risk factors and ultrasound-guided attenuation parameter (UGAP)-diagnosed hepatic steatosis in children with obesity, evaluate variables associated with steatosis, and explore the diagnostic performance of alanine aminotransferase (ALT). This single-center, cross-sectional study included 91 children aged ≥ 9 years with obesity recruited from pediatric endocrinology and gastroenterology outpatient clinics between July 2023 and July 2025. Anthropometric, blood pressure, biochemical, and UGAP measurements were collected. Hepatic steatosis was defined as UGAP ≥ 0.680 dB/cm/MHz. Elevated ALT was defined as ≥ 44 U/L in females and ≥ 52 U/L in males. Associations with hepatic steatosis were assessed using Poisson regression. The prevalence of UGAP-diagnosed hepatic steatosis was 28.6%. Higher BMI z-score, larger waist circumference, elevated ALT, arterial hypertension, dyslipidemia, insulin resistance, and metabolic syndrome were significantly associated with hepatic steatosis. Elevated ALT showed low sensitivity (19.2%) and high specificity (93.8%) for detecting hepatic steatosis. ALT discriminatory performance differed by sex, with an AUC of 0.816 in females and 0.582 in males. Exploratory ALT cutoffs showed limited clinical applicability, particularly in males because of very low specificity. Children with obesity and UGAP-diagnosed hepatic steatosis showed a more unfavorable cardiometabolic profile. ALT alone may miss a substantial proportion of children with hepatic steatosis, supporting the need for improved screening strategies. • Pediatric hepatic steatosis is associated with an adverse cardiometabolic profile in children with obesity. • Screening strategies based on ALT and imaging techniques show variable diagnostic performance in pediatric populations. • UGAP-diagnosed hepatic steatosis in children with obesity was associated with an unfavorable cardiometabolic profile in a Spanish secondary-care cohort. • ALT showed sex-specific differences and limited usefulness as a standalone screening tool for hepatic steatosis, particularly in males, when UGAP was used as the reference method.